Viagra can teach us a lot about treating rare diseases
Before it conquered the world, Viagra was a failing angina drug, and its potential was almost missed. Healx wants to ensure we don’t overlook other therapies
PharmEnable and LifeArc transcend vaccines to fight coronaviruses
AI drug discovery company PharmEnable and medical research charity LifeArc are collaborating to discover novel oral antiviral drugs with activity against coronaviruses.
Featurespace files two global patents for its fraud prevention technology
Featurespace has filed two global patents for its fraud prevention and anti-money laundering technology.
Arecor Therapeutics focused on Phase 1 trial of diabetes treatment AT278
A key focus for the second half of 2021 is the Phase I clinical trial for AT278 which, if successful, would add significantly to Arecor's diabetes franchise
Online fraudsters in the cross hairs of Featurespace sharpshooters
Life has just got tougher for online financial fraudsters after Cambridge-based Featurespace added two powerful weapons to its online defence armoury.
Paragraf™ nominated for Automotive Product of the Year Award
The Electronics Industry Awards, organised by Components in Electronics (CIE) publisher Datateam Business Media, is back for 2021 to celebrate the very best professionals, products, projects and companies from across the electronics sector.
Tripism's Adam Kerr on Trying to Build a Better Travel Intranet
First piloted six years ago to serve as the corporate travel intranet for Microsoft, Tripism since has expanded into a travel planning and engagement provider for a range of large companies.
PervasID pivots to overcome pandemic impact with Innovate UK EDGE help
A spin-out from Cambridge University has had support from Innovate UK EDGE to pivot into new markets with its patented inventory tracking system, after orders from the aviation spares industry collapsed during the COVID-19 crisis.
PervasID CEO & founder receives silver medal from the Royal Academy of Engineering
The CEO and founder of PervasID, the Cambridge-based battery-free RFID technology innovator used in healthcare, retail and manufacturing, has been recognised with a prestigious honour.
Cambridge Cognition spin-out targets schizophrenia and post-operative cognitive dysfunction
Monument Therapeutics, a stratified medicine company, today announced it has raised £2.625 million in seed funding to spin out of Cambridge Cognition Ltd and relocate to Alderley Park, Cheshire.
New chairman at BioTech Phico
Phico Therapeutics, a biotechnology company developing a new generation of antibiotics to overcome antibacterial resistance, has appointed a new chairman.
Consumer research shows strong demand for smart(er)phones that react to the world around them
Sound recognition will deliver a wave of new experiences on smartphones, and Audio Analytic's recent consumer research clearly shows a strong desire from users for these new AI-powered capabilities on their next device.
Porotech raises £3m for new generation of microdisplays
Unique approach enables brighter, sharper, more vivid displays for smart devices
Cambridge company is unlocking secrets of proteins after RSC Emerging Technologies Competition win
HexagonFab won the Enabling Technologies category 2018
Rovco, PanGeo form subsea partnership
Rovco and PanGeo Subsea will collaborate to assess changing subsea component/environmental conditions that may lead to wider problems without planned intervention.
Wazoku appoints Martin Fincham as Chairman
Innovation scale-up Wazoku has appointed Martin Fincham as its new Chairman, as the company continues to expand its senior team ahead of growth and further expansion in 2021.
CyberSmart disrupts SME cybersecurity with $10 million Series A funding
CyberSmart, UK leader in simple and accessible automated cybersecurity technology for SMEs, has today announced the completion of a successful over-subscribed Series A funding round, bringing the total raised to over $10 million.
Healx CEO Tim Guilliams among East of England finalists in EY’s Entrepreneur of the Year UK competition
Tim Guilliams, co-founder and CEO of Healx, is one of five East of England finalists in EY’s Entrepreneur of the Year UK programme.
PhoreMost appoints Christian Dillon as Vice President of Biology
PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, today announced it has appointed Dr. Christian Dillon as Vice President of Biology.
Arecor Therapeutics appoints Lindsey Foulkes as chief operating officer
Dr Lindsey Foulkes has joined the executive team at Arecor.